🇺🇸 FDA

Drug profile · INN

dexlansoprazole

DEXLANSOPRAZOLE

approved
US status
approved
Patents linked
6
News articles
0

Quick answer

dexlansoprazole (DEXLANSOPRAZOLE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN dexlansoprazole
Brand DEXLANSOPRAZOLE
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Related patents

Search patents →

Frequently asked questions

What is dexlansoprazole?

dexlansoprazole (DEXLANSOPRAZOLE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for dexlansoprazole?

DEXLANSOPRAZOLE is a marketed brand name for dexlansoprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dexlansoprazole?

dexlansoprazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.